Stock Events

Stock Events

Pulse Biosciences 

€19.5
8
+€1+5.41% Thursday 06:05

Statistics

Day High
17.1
Day Low
17.1
52W High
21.4
52W Low
10.8
Volume
-
Avg. Volume
-
Mkt Cap
1.33B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.31
-0.26
-0.21
-0.16
Expected EPS
-0.27
Actual EPS
N/A

Financials

-20,983.95%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
596,573.76Revenue
-125.18MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 6L8.F. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Boston Scientific
BSX
Mkt Cap93.36B
Boston Scientific Corporation offers a wide range of medical devices that compete in the cardiovascular and neuromodulation markets, overlapping with Pulse Biosciences' therapeutic areas.
Medtronic
MDT
Mkt Cap111.22B
Medtronic is a global leader in medical technology, services, and solutions, competing across several of Pulse Biosciences' key areas, including cardiac and vascular therapies.
Intuitive Surgical
ISRG
Mkt Cap160.56B
Intuitive Surgical, known for its da Vinci surgical systems, competes with Pulse Biosciences in the field of minimally invasive surgery, albeit through different technological approaches.
Stryker
SYK
Mkt Cap126.97B
Stryker is a medical technologies firm that competes with Pulse Biosciences in the development of surgical and neurotechnology products.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet Holdings, Inc. competes in the musculoskeletal healthcare sector, offering products that can be seen as alternatives to Pulse Biosciences' treatments.
Edwards Lifesciences
EW
Mkt Cap48.41B
Edwards Lifesciences specializes in heart valves and hemodynamic monitoring, competing with Pulse Biosciences in the broader field of medical devices for cardiovascular health.
Hologic
HOLX
Mkt Cap16.45B
Hologic, Inc. focuses on diagnostics, medical imaging systems, and surgical products for women's health, competing with Pulse Biosciences in the medical device market.
Baxter International
BAX
Mkt Cap8.61B
Baxter International Inc. provides a broad portfolio of renal and hospital products, including bio-surgery products that compete with Pulse Biosciences' offerings in the surgical market.

About

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
Show more...
CEO
Mr. Paul Arthur LaViolette
Employees
75
Country
US
ISIN
US74587B1017
WKN
000A2AMY9

Listings

F
DE
6L8.F
XNAS
US
PLSE
BOATS
BOATS
PLSE.BOATS

0 Comments

Share your thoughts

FAQ

What is Pulse Biosciences stock price today?▼
The current price of 6L8.F is €19.5 EUR — it has increased by +5.41% in the past 24 hours. Watch Pulse Biosciences stock price performance more closely on the chart.
What is Pulse Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Pulse Biosciences stocks are traded under the ticker 6L8.F.
Is Pulse Biosciences stock price growing?▼
6L8.F stock has risen by +11.43% compared to the previous week, the month change is a +23.42% rise, over the last year Pulse Biosciences has showed a +45.52% increase.
What is Pulse Biosciences market cap?▼
Today Pulse Biosciences has the market capitalization of 1.33B
When is the next Pulse Biosciences earnings date?▼
Pulse Biosciences is going to release the next earnings report on May 07, 2026.
What were Pulse Biosciences earnings last quarter?▼
6L8.F earnings for the last quarter are -0.16 EUR per share, whereas the estimation was -0.23 EUR resulting in a +31% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Pulse Biosciences revenue for the last year?▼
Pulse Biosciences revenue for the last year amounts to 596,573.76 EUR.
What is Pulse Biosciences net income for the last year?▼
6L8.F net income for the last year is -125.18M EUR.
How many employees does Pulse Biosciences have?▼
As of April 06, 2026, the company has 75 employees.
In which sector is Pulse Biosciences located?▼
Pulse Biosciences operates in the Health Care sector.
When did Pulse Biosciences complete a stock split?▼
Pulse Biosciences has not had any recent stock splits.
Where is Pulse Biosciences headquartered?▼
Pulse Biosciences is headquartered in Miami, US.